Persistent edematous-plaque photosensitivity observed with sitagliptin phosphate (Januvia®)

Dermatol Online J. 2012 Feb 15;18(2):9.

Abstract

Photosensitivity to sitagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, is reported. No previous reports of photosensitivity to any DPP-4 inhibitors are known. Physical examination of the patient revealed edematous plaques confined to sun-exposed areas of the skin. An unusual finding in this case was the spongy sensation upon palpation of the plaques. Histopathology revealed parakeratosis and abundant eosinophils, supporting the clinical impression of cutaneous drug sensitivity. The eruption finally cleared, approximately two years after onset.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Diabetes Mellitus, Type 2 / drug therapy
  • Dipeptidyl-Peptidase IV Inhibitors / adverse effects*
  • Humans
  • Hypoglycemic Agents / adverse effects*
  • Hypoglycemic Agents / therapeutic use
  • Male
  • Photosensitivity Disorders / chemically induced*
  • Photosensitivity Disorders / diagnosis
  • Photosensitivity Disorders / pathology
  • Protective Clothing
  • Pyrazines / adverse effects*
  • Sitagliptin Phosphate
  • Treatment Outcome
  • Triazoles / adverse effects*

Substances

  • Dipeptidyl-Peptidase IV Inhibitors
  • Hypoglycemic Agents
  • Pyrazines
  • Triazoles
  • Sitagliptin Phosphate